Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-jr42d Total loading time: 0 Render date: 2024-04-24T10:40:27.543Z Has data issue: false hasContentIssue false

Chapter 14 - Tumors of the gastrointestinal system

Published online by Cambridge University Press:  05 November 2015

By
Manuel Salto-Tellez ,
Benedict Yan ,
Roseann I. Wu  and
Martha Bishop Pitman
Edited by
John M. S. Bartlett ,
Abeer Shaaban  and
Fernando Schmitt
John M. S. Bartlett
Affiliation:
Ontario Institute for Cancer Research, Toronto
Abeer Shaaban
Affiliation:
Queen Elizabeth Hospital Birmingham
Fernando Schmitt
Affiliation:
University of Porto
Get access
Type
Chapter
Information
Molecular Pathology
A Practical Guide for the Surgical Pathologist and Cytopathologist
 , pp. 200 - 221
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Van Schaeybroeck, S., Lawler, M., Johnston, B., Salto-Tellez, M., Lee, J., Loughlin, P. et al. Colorectal Cancer. Chapter 77 in Abeloff's Clinical Oncology, 5th edn. (Philadelphia, PA: Elsevier-Saunders, 2014).Google Scholar
Hisamuddin, I. M. and Yang, V. W. Genetics of colorectal cancer. MedGenMed 2004; 6(3): 13.Google ScholarPubMed
http://surgpathcriteria.stanford.edu/gitumors/familial-adenomatous-polyposis/.Google Scholar
Subramaniam, M. M., Putti, T. C., Anuar, D., Chong, P. Y., Shah, N., Salto-Tellez, M. et al. Clonal characterization of sporadic cribriform-morular variant of papillary thyroid carcinoma by laser microdissection-based APC mutation analysis. Am J Clin Pathol 2007; 128(6): 994–1001.CrossRefGoogle ScholarPubMed
Goodenberger, M. and Lindor, N. M. Lynch syndrome and MYH-associated polyposis: review and testing strategy. J Clin Gastroenterol 2011; 45(6): 488–500.CrossRefGoogle ScholarPubMed
De Roock, W., Claes, B., Bernasconi, D., De Schutter, J., Biesmans, B., Fountzilas, G. et al. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis. Lancet Oncol 2010; 11(8): 753–62.CrossRefGoogle ScholarPubMed
Kamel-Reid, S., Zhang, T., Persons, D. L., Nikiforova, M. N., Halling, K. C. and Molecular Oncology Resource Committee of the College of American Pathologists. Validation of KRAS testing for anti-EGFR therapeutic decisions for patients with metastatic colorectal carcinoma. Arch Pathol Lab Med 2012; 136(1): 26–32.CrossRefGoogle ScholarPubMed
Sharma, S. G. and Gulley, M. L. BRAF mutation testing in colorectal cancer. Arch Pathol Lab Med 2010; 134(8): 1225–8.CrossRefGoogle ScholarPubMed
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S. et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417(6892): 949–54.CrossRefGoogle ScholarPubMed
Whitehall, V., Tran, K., Umapathy, A., Grieu, F., Hewitt, C., Evans, T. J. et al. A multicenter blinded study to evaluate KRAS mutation testing methodologies in the clinical setting. J Mol Diagn 2009; 11(6): 543–52.CrossRefGoogle ScholarPubMed
Popat, S., Matakidou, A. and Houlston, R. S. Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. J Clin Oncol 2004; 22(3): 529–36.CrossRefGoogle ScholarPubMed
Sinicrope, F. A. and Sargent, D. J. Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications. Clin Cancer Res 2012; 18(6): 1506–12.CrossRefGoogle ScholarPubMed
Vilar, E. and Tabernero, J. Molecular dissection of microsatellite instable colorectal cancer. Cancer Discov 2013; 3(5): 502–11.CrossRefGoogle ScholarPubMed
Liao, X., Lochhead, P., Nishihara, R., Morikawa, T., Kuchiba, A., Yamauchi, M. et al. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. New Engl J Med 2012; 367(17): 1596–606.CrossRefGoogle ScholarPubMed
Kelley, R. K. and Venook, A. P. Prognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling? Clin Colorectal Cancer 2011; 10(2): 73–80.CrossRefGoogle Scholar
Gray, R. G., Quirke, P., Handley, K., Lopatin, M., Magill, L., Baehner, F. L. et al. Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer. J Clin Oncol 2011; 29(35): 4611–19.CrossRefGoogle ScholarPubMed
Kennedy, R. D., Bylesjo, M., Kerr, P., Davison, T., Black, J. M., Kay, E. W. et al. Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue. J Clin Oncol 2011; 29(35): 4620–6.CrossRefGoogle ScholarPubMed
Bang, Y. J., Van Cutsem, E., Feyereislova, A., Chung, H. C., Shen, L., Sawaki, A. et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010; 376(9742): 687–97.CrossRefGoogle ScholarPubMed
Salto-Tellez, M., Yau, E. X., Yan, B. and Fox, S. B. Where and by whom should gastric cancer HER2/neu status be assessed? Lessons from breast cancer. Arch Pathol Lab Med 2011; 135(6): 693–5.CrossRefGoogle ScholarPubMed
Tay, C. M., Ong, C. W., Lee, V. K. and Pang, B. KIT gene mutation analysis in solid tumours: biology, clinical applications and trends in diagnostic reporting. Pathology 2013; 45(2): 127–37.Google Scholar
Salto-Tellez, M. and Koay, E. S. Molecular diagnostic cytopathology: definitions, scope and clinical utility. Cytopathology 2004; 15(5): 252–5.CrossRefGoogle ScholarPubMed
Pang, N. K., Nga, M. E., Chin, S. Y., Ismail, T. M., Lim, G. L., Soong, R. et al. KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinoma. Cytopathology 2011; 22(6): 358–64.CrossRefGoogle ScholarPubMed
Pang, N. K., Chin, S. Y., Nga, M. E., Chang, A. R., Ismail, T. M., Omar, S. S. et al. Comparative validation of c-kit exon 11 mutation analysis on cytology samples and corresponding surgical resections of gastrointestinal stromal tumours. Cytopathology 2009; 20(5): 297–303.CrossRefGoogle ScholarPubMed
Macgregor-Das, A. M. and Iacobuzio-Donahue, C. A. Molecular pathways in pancreatic carcinogenesis. J Surg Oncol 2013; 107(1): 8–14.CrossRefGoogle ScholarPubMed
Matthaei, H., Norris, A. L., Tsiatis, A. C., Olino, K., Hong, S. M., dal Molin, M. et al. Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2012; 255(2): 326–33.CrossRefGoogle ScholarPubMed
Wu, J., Matthaei, H., Maitra, A., Dal Molin, M., Wood, L. D., Eshleman, J. R. et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med 2011; 3(92): 92ra66.CrossRefGoogle ScholarPubMed
Kanda, M., Knight, S., Topazian, M., Syngal, S., Farrell, J., Lee, J. et al. Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut 2013; 62(7): 1024–33.CrossRefGoogle ScholarPubMed
Pitman, M. B. Diagnostic investigation of pancreatic cyst fluid, in Tanaka, M. (ed.), Intraductal Papillary Mucinous Neoplasm of the Pancreas (Osaka: Springer Japan, 2013).Google Scholar
Khalid, A., McGrath, K. M., Zahid, M., Wilson, M., Brody, D., Swalsky, P. et al. The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology. Clin Gastroenterol Hepatol 2005; 3(10): 967–73.CrossRefGoogle ScholarPubMed
Melton, S. D., Genta, R. M. and Souza, R. F. Biomarkers and molecular diagnosis of gastrointestinal and pancreatic neoplasms. Nat Rev Gastroenterol Hepatol 2010; 7(11): 620–8.CrossRefGoogle ScholarPubMed
Hsu, M., Sasaki, M., Igarashi, S., Sato, Y. and Nakanuma, Y. KRAS and GNAS mutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas. Cancer 2013; 119(9): 1669–74.CrossRefGoogle ScholarPubMed
Sturm, P. D., Rauws, E. A., Hruban, R. H., Caspers, E., Ramsoekh, T. B., Huibregtse, K. et al. Clinical value of K-ras codon 12 analysis and endobiliary brush cytology for the diagnosis of malignant extrahepatic bile duct stenosis. Clin Cancer Res 1999; 5(3): 629–35.Google ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×